Tomudex 2 mg
Tomudex 2 mg is a medicine authorised by Swissmedic under authorisation number 53536. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 May 1998 and the authorisation is valid without a time limit. ATC code L01BA03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 53536 |
|---|---|
| Name | Tomudex 2 mg |
| Full name | Tomudex 2 mg, Pulver zur Herstellung einer Infusionslösung |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01BA03 |
| First authorisation | 28 May 1998 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tomudex 2 mg, Pulver zur Herstellung einer Infusionslösung | A | 28 May 1998 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 18 | 1 | Durchstechflasche(n) | L01BA03 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Tomudex 2 mg authorised in Switzerland?
Yes. Tomudex 2 mg is authorised by Swissmedic under authorisation number 53536, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tomudex 2 mg have?
Tomudex 2 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tomudex 2 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.